MANHARD KIMBERLY has filed 3 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 15000 shares of Inhibrx Biosciences, Inc. ($INBX) on May 28, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28, 2025 | Inhibrx Biosciences, Inc. | $INBX | MANHARD KIMBERLY | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 14,476,000 | 9999.99% | 0.10% |
| Aug. 28, 2024 | Inhibrx Biosciences, Inc. | $INBX | MANHARD KIMBERLY | Director | P | Common Stock | 10000 | $13.98 | 10,000.0000 | 14,476,000 | 9999.99% | 0.07% |
| May 30, 2024 | Inhibrx Biosciences, Inc. | $INBX | MANHARD KIMBERLY | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 14,475,904 | 9999.99% | 0.21% |